Evidence 1
Activity
Activity
25% Hemolysis
Toxicity
500 µg/mL
Hemolytic
Cytotoxic
25% Hemolysis | 500 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA). | Nanotechnology | 2017